Syndrome News and Research

RSS

Delta variant exhibits immune evasion, enhanced cell entry, and augmented syncytium formation

Researchers addressed the question of using reporter particles pseudotyped with the S protein of SARS-CoV-2, which are suitable tools to examine SARS-CoV-2 neutralization antibodies.

11 Oct 2021

Prior immunity to influenza, not SARS-CoV-2, prevents severe disease and mortality

Researchers from the Israel Institute of Biological Research delineated the interplay between IAV and SARS CoV-2 infections.

11 Oct 2021

Vaccine-induced memory B cells can recognize SARS-CoV-2 variants

Researchers have been investigating the effect that memory B cells produced in individuals who have received an mRNA vaccine have against SARS-CoV-2 variants.

11 Oct 2021

Better clinical outcomes in COVID-19 and vaccine-related myocarditis than classic myocarditis in children

Researchers have investigated the differences between 'classic' myocarditis, COVID-19 induced myocarditis, and vaccine-related myocarditis.

11 Oct 2021

Sero-epidemiological insights into pathways to COVID-19 immunity

A new study posted to the medRxiv* server attempts to utilize serology as a tool to identify disparities in infection rates and vaccination coverage.

10 Oct 2021

Research finds different antibody responses following COVID vaccination and natural infection

A new study published in the journal Nature attempted to investigate memory B cell evolution 5 months after vaccination with mRNA vaccines such as Moderna (mRNA-1273) or Pfizer-BioNTech (BNT162b2) in SARS-CoV-2 naïve individuals. The study explored various aspects of memory B cell antibody response like neutralizing response, affinity, epitope targeting, and neutralizing breadth.

10 Oct 2021

The neurological effects of COVID-19

What is the relationship between COVID-19 and the brain? A new review published in Tropical Biomedicine summarizes the key findings on how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes severe COVID-19 infection, disrupts brain activity and produces a range of long-term neurological disorders.

10 Oct 2021

Accumulation of SARS-CoV-2 mutations reduces sensitivity to neutralizing antibodies

In a new study, researchers discovered that SARS-CoV-2 mutations accumulate, especially in immunocompromised patients.

10 Oct 2021

COVID-19 vaccination rates among minority populations

A new study discusses offers insights into how minority groups can be effectively persuaded to take the currently available COVID-19 vaccines.

10 Oct 2021

Inactivated polio vaccine induces antibodies that block SARS-CoV-2 RNA synthesis

A new study introduces the possibility that the inactivated polio vaccine can elicit antibodies that inhibit SARS-CoV-2 nucleic acid synthesis.

10 Oct 2021

Prenatal maternal distress during COVID linked to alterations in infant brain development

A new study discusses the effects of stress during pregnancy in the pandemic on the developing brain of the infant.

10 Oct 2021

Phase I clinical trial of two Cuban recombinant protein COVID-19 vaccines

The results of Phase I clinical trials for two new COVID-19 vaccine candidates based on recombinant RDB proteins are reported.

10 Oct 2021

What impact does temperature have on SARS-CoV-2 M protein dynamics?

In a recent study, the structural dynamics of the SARS-CoV-2 M protein are studied at temperatures of 10-50 ˚C using molecular dynamics simulations.

10 Oct 2021

Qatari study finds BNT162b2 vaccine effectiveness waning 6 months after second dose

The researchers assessed the effectiveness of the BNT162b2 vaccine against SARS-CoV-2 infection and COVID-19-related hospitalization and deaths.

10 Oct 2021

Dynamic causal modeling for future projection of the COVID-19 pandemic

A new study utilizes dynamic causal modeling to predict the effects of letting SARS-CoV-2 sweep through a largely vaccinated population.

10 Oct 2021

Lipids, COVID-19, and host immunity

A new study from a team of researchers at the University of Pennsylvania examines the role played by lipids in this disease.

10 Oct 2021

Powerful neutralizing antibody against SARS-CoV-2 variants of concern

A new paper discusses a new antibody with potent neutralizing activity against the ancestral SARS-CoV-2 strain, as well as newer variants of SARS-CoV-2.

10 Oct 2021

Role of S-acylation in SARS-CoV-2 infectivity

A new study published in Developmental Cell investigates S-acylation of the SARS-CoV-2 S protein.

10 Oct 2021

Tracking ADHD symptoms, behavior in people with intellectual disability using a smartphone app

A new study by the UC Davis MIND Institute's David Hessl will test whether a smartphone-based app may help improve the accuracy of data in some clinical trials involving individuals with intellectual disability.

8 Oct 2021

Study aims to find ways of identifying children at risk for severe COVID-19

An ongoing study is looking at the relationship between cytokines in saliva and COVID-19 infection to help predict the severity of infection.

8 Oct 2021

Syndrome News and Research

Delta variant exhibits immune evasion, enhanced cell entry, and augmented syncytium formation

Prior immunity to influenza, not SARS-CoV-2, prevents severe disease and mortality

Vaccine-induced memory B cells can recognize SARS-CoV-2 variants

Better clinical outcomes in COVID-19 and vaccine-related myocarditis than classic myocarditis in children

Sero-epidemiological insights into pathways to COVID-19 immunity

Research finds different antibody responses following COVID vaccination and natural infection

The neurological effects of COVID-19

Accumulation of SARS-CoV-2 mutations reduces sensitivity to neutralizing antibodies

COVID-19 vaccination rates among minority populations

Inactivated polio vaccine induces antibodies that block SARS-CoV-2 RNA synthesis

Prenatal maternal distress during COVID linked to alterations in infant brain development

Phase I clinical trial of two Cuban recombinant protein COVID-19 vaccines

What impact does temperature have on SARS-CoV-2 M protein dynamics?

Qatari study finds BNT162b2 vaccine effectiveness waning 6 months after second dose

Dynamic causal modeling for future projection of the COVID-19 pandemic

Lipids, COVID-19, and host immunity

Powerful neutralizing antibody against SARS-CoV-2 variants of concern

Role of S-acylation in SARS-CoV-2 infectivity

Tracking ADHD symptoms, behavior in people with intellectual disability using a smartphone app

Study aims to find ways of identifying children at risk for severe COVID-19

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News